Limited Edition Golden Llama is here! Check out how you can get one. Limited Edition Golden Llama is here! Check out how you can get one.
Offering SPR-BLI Services - Proteins provided for free! Offering SPR-BLI Services - Proteins provided for free!
Thank you for choosing ACROBiosystems. Would you rate our product and service? Thank you for choosing ACROBiosystems. Would you rate our product and service?
Here come GMP Grade Cytokines!Free Sample is available! Here come GMP Grade Cytokines!Free Sample is available!
Project Name | Modality | Therapeutic Area | Indications | Stage | Right Available |
CD37+CD22 CAR-T | Cell therapy | Oncology/Cancer | AML | PCC | Global |
製造番号 | 種類 | 製品説明 | 構造 | 純度 | 特徴 |
---|---|---|---|---|---|
CD7-H52P4 | Human | Human CD37 Full Length Protein (VLP) | |||
CD7-H52H3 | Human | Human CD37 Protein, His Tag |
|
||
CD7-HF26x | Human | FITC-Labeled Human CD37 Protein, Fc Tag |
|
||
CD7-H525a | Human | Human CD37 Protein, Fc Tag (MALS verified) |
|
||
CD7-H526x | Human | Human CD37 Protein, Fc Tag |
|
Please contact us via TechSupport@acrobiosystems.com if you have any question on this product.
Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
---|---|---|---|---|---|
Lutetium (177lu) lilotomab satetraxetan | 177Lu-DOTA-HH1 | Phase 2 Clinical | Nordic Nanovector | Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Follicular; Lymphoma, Non-Hodgkin | Details |
Naratuximab emtansine | IMGN-529; K7153A-SMCC-DM1 | Phase 2 Clinical | Immunogen Inc | Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Leukemia, Lymphocytic, Chronic, B-Cell | Details |
AGS-67E | AGS-67E | Phase 1 Clinical | Agensys Inc | Leukemia, Hairy Cell; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Leukemia, Lymphocytic, Chronic, B-Cell | Details |
BI-836826 | mAb-37.1; mAb-37.2; BI-836826 | Phase 1 Clinical | C.H. Boehringer Sohn Ag & Co. Kg | Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Leukemia, Lymphocytic, Chronic, B-Cell | Details |
CAR-37 T cell therapy (Massachusetts General Hospital) | Phase 1 Clinical | Massachusetts General Hospital | Lymphoma, B-Cell; Leukemia; Hematologic Neoplasms; Lymphoma; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell | Details | |
QLP-31907 | QLP-31907; QLP31907; PSB-202 | Phase 1 Clinical | Qilu Pharmaceutical Co Ltd | Lymphoma, B-Cell; Lymphoma, B-Cell, Marginal Zone; Lymphoma, Follicular; Lymphoma, Mantle-Cell; Waldenstrom Macroglobulinemia; Lymphoma, Non-Hodgkin; Leukemia, Lymphocytic, Chronic, B-Cell | Details |
Lutetium (177lu) lilotomab satetraxetan | 177Lu-DOTA-HH1 | Phase 2 Clinical | Nordic Nanovector | Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Follicular; Lymphoma, Non-Hodgkin | Details |
Naratuximab emtansine | IMGN-529; K7153A-SMCC-DM1 | Phase 2 Clinical | Immunogen Inc | Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Leukemia, Lymphocytic, Chronic, B-Cell | Details |
AGS-67E | AGS-67E | Phase 1 Clinical | Agensys Inc | Leukemia, Hairy Cell; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Leukemia, Lymphocytic, Chronic, B-Cell | Details |
BI-836826 | mAb-37.1; mAb-37.2; BI-836826 | Phase 1 Clinical | C.H. Boehringer Sohn Ag & Co. Kg | Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Leukemia, Lymphocytic, Chronic, B-Cell | Details |
CAR-37 T cell therapy (Massachusetts General Hospital) | Phase 1 Clinical | Massachusetts General Hospital | Lymphoma, B-Cell; Leukemia; Hematologic Neoplasms; Lymphoma; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell | Details | |
QLP-31907 | QLP-31907; QLP31907; PSB-202 | Phase 1 Clinical | Qilu Pharmaceutical Co Ltd | Lymphoma, B-Cell; Lymphoma, B-Cell, Marginal Zone; Lymphoma, Follicular; Lymphoma, Mantle-Cell; Waldenstrom Macroglobulinemia; Lymphoma, Non-Hodgkin; Leukemia, Lymphocytic, Chronic, B-Cell | Details |
This web search service is supported by Google Inc.